Pune, India -- (SBWire) -- 09/05/2018 --We have produced a new premium report Lung Cancer Therapeutics Market. The report covers the analysis of global as well as regional markets of Lung Cancer Therapeutics. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of Lung Cancer Therapeutics Market by molecule (small molecules, biologics), disease type (NSCLC, SCLC) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.
The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the Lung Cancer Therapeutics Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Lung Cancer Therapeutics Market are Astellas Pharma, Pfizer, Amgen, Celgene, AstraZeneca, F. Hofmann-La Roche, GlaxoSmithKline, Aetna, Agennix, Eli Lilly and Boston Biomedical.
For More Details Get Free Sample Pages of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1185
The report also identifies the drivers and restraints that affect the Lung Cancer Therapeutics market over the period of 2018 to 2024.
Adoption of targeted therapy
One of the latest trend in the market is increasing adoption of targeted therapy which is anticipated to drive the global lung cancer therapeutics market over the forecast period. Moreover, key factors responsible for increasing adoption of targeted therapy over conventional therapies are better efficiency and lesser side effects as compare to chemotherapy and radiation therapy.
Growing incidences of lung cancer
Growing incidence of lung cancer due to unhealthy lifestyle is one of the prime factor responsible for the growth of global lung cancer therapeutics market. Moreover, rising prevalence of lung cancer due to increasing smoking population and unhealthy lifestyle are the key factors responsible for the growth in the incidences of lung cancer cases.
North America region is the largest consumer among the geographies followed by Europe while APAC to grow at a highest CAGR
The global Lung Cancer Therapeutics market has been dominated by the North America region over the historic period 2015-16 followed by Europe. Huge lung cancer patient pool and growing adoption of targeted therapies across the region are the key factors responsible for the growth of this market in the North America region. Furthermore, the Asia-Pacific region is expected to grow at a highest CAGR over the period of 2018 to 2024. Moreover, improvement in healthcare facilities, rising awareness among people regarding lung cancer and as well as increase in population coupled with unhealthy lifestyle are anticipated to boost the market for Lung Cancer Therapeutics.
Major Key Players mentioned in this Premium Report
The companies covered in the report include Astellas Pharma, Pfizer, Amgen, Celgene, AstraZeneca, F. Hofmann-La Roche, GlaxoSmithKline, Aetna, Agennix, Eli Lilly and Boston Biomedical.
Purchase Global Lung Cancer Therapeutics market by type of molecule (small molecules and biologics), by disease type (NSCLC and SCLC) and by region (North America, Europe, Asia Pacific, Latin America and RoW) report on https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-lung-cancer-therapeutics-market
Reasons to buy this report
Comprehensive analysis of global as well as regional markets of Lung Cancer Therapeutics
Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
Overview of Lung Cancer Therapeutics Market with Production, Trends, Price, Revenue, Share, Growth and Forecast Until 2024
The report also deep dives into the sub-segments of Lung Cancer Therapeutics Market by molecule (small molecules, biologics), disease type (NSCLC, SCLC) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.